Macrophage activation and hemophagocytic syndrome in Langerhans cell histiocytosis: Report of 30 cases

Pediatric and Developmental Pathology

Volumn 5, Issue 2, 2002, Pages 130-140

  Favara, Blaise E ^a,b   Jaffe, Ronald ^c,d   Egeler, R Maarten ^e,f,g  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^e LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^f TOM BAKER CANCER CENTRE   (Canada)

^g UNIVERSITY OF CALGARY   (Canada)

Author keywords

Hemophagocytic syndrome; Histiocytosis; Langerhans cell histiocytosis; Pediatric

Indexed keywords

CYTOKINE;

ARTICLE; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; DISEASE CLASSIFICATION; ERYTHROPHAGOCYTOSIS; FEMALE; HISTIOCYTOSIS X; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOPATHOLOGY; INFANT; MACROPHAGE ACTIVATION; MALE; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; T LYMPHOCYTE;

ADOLESCENT; AGE FACTORS; CHILD; CHILD, PRESCHOOL; FATAL OUTCOME; FEMALE; HISTIOCYTOSIS, LANGERHANS-CELL; HISTIOCYTOSIS, NON-LANGERHANS-CELL; HUMANS; INFANT; INFANT, NEWBORN; MACROPHAGE ACTIVATION; MALE;

EID: 0036254727     PISSN: 10935266     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10024001-0159-2     Document Type: Article

References (55)

1. Contemporary classification of histiocytic disorders of childhood
2. Langerhans-cell histiocytosis (histiocytosis X): A clonal proliferative disease
3. Nosology and pathology of Langerhans cell histiocytosis
4. Hemophagocytic lymphohistiocytosis: A hemophagocytic syndrome
5. Lymphohistiocytosis: A multi-factorial syndrome of macrophagic activation. Clinico-pathological study of 38 cases
6. Differential in situ cytokine profiles of Langerhans-like cells and T cells in Langerhans cell histiocytosis: Abundant expression of cytokines relevant to disease and treatment
7. An update on clonality, cytokines, and viral etiology of Langerhans cell histiocytosis
8. The presence of cytokines in Langerhans cell histiocytosis
9. The role of cytokines in the pathogenesis of Langerhans cell histiocytosis
10. Hypercytokinemia in familial hemophagocytic lymphohistiocytosis
11. Infection and malignancy-associated hemophagocytic syndromes, secondary hemophagocytic lymphohistiocytosis
12. Inflammatory cytokines in virus-associated hemophagocytic syndrome. Interferon-gamma as a sensitive indicator of disease activity
13. Histopathology of the liver in histiocytosis syndromes
14. Langerhans cell histiocytosis of lymph nodes: A morphological assessment of forty-three biopsies
15. Current therapy of Langerhans cell histiocytosis
16. Up-regulation of adhesion and MHC molecules on splenic monocyte/macrophages in adult haemophagocytic syndrome
17. Disseminated histocytosis X complicated by diffuse erythrophagocytosis: Report of two cases
18. Simultaneous occurrence of viral-associated hemophagocytic syndrome and Langerhans cell histiocytosis: A case report
19. Recurrent viral associated hemophagocytic syndrome in a child with Langerhans cell histiocytosis
20. Images in haematology. Langerhans cell histiocytosis
21. Perforin gene defects in familial hemophagocytic lymphohistiocytosis
22. Hemophagocytic lymphohistiocytosis due to germline mutations in SH2D1A, the X-linked lymphoproliferative disease gene
23. Familial hemophagocytic lymphohistiocytosis, primary hemophagocytic lymphohistiocytosis
24. Hemophagocytic syndromes and infection
25. Haemophagocytic lymphohistiocytosis, interferon-gamma-naemia and Epstein-Barr virus involvement
26. Upregulation of tumor necrosis factor-alpha gene by Epstein-Barr virus and activation of macrophages in Epstein-Barr virus-infected T cells in the pathogenesis of hemophagocytic syndrome
27. Clinicopathological study of severe chronic active Epstein-Barr virus infection that developed in association with lymphoproliferative disorder and/or hemophagocytic syndrome
28. Outcome of clonal hemophagocytic lymphohistiocytosis: Analysis of 32 cases
29. Biomarker and morphological characteristics of Epstein-Barr virus-related hemophagocytic lymphohistiocytosis
30. Elevated soluble interleukin-2 receptor in childhood hemophagocytic histiocytic syndromes
31. Immunohistochemical detection of granulocyte/macrophage colony-stimulating factor in Langerhans cell histiocytosis
32. Expression of GM-CSF receptor by Langerhans cell histiocytosis cells
33. Prostaglandins in histiocytosis-X
34. +) cells from bone granuloma produce interleukin 1 and prostaglandin E2 in culture
35. Central nervous system involvement in the erythrophagocytic disorders of infancy: The role of cerebrospinal fluid neopterins in their differential diagnosis and clinical management
36. Detection of GMCSF in the sera of children with Langerhans cell histiocytosis
37. Langerhans cell histiocytosis in children: Does soluble interleukin-2-receptor correlate with both disease extent and activity?
38. Abundant expression of CD40 and CD40-ligand (CD154) in paediatric Langerhans cell histiocytosis lesions
39. Hypercytokinemia in hemophagocytic syndrome
40. Cytokine production regulating Th1 and Th2 cytokines in hemophagocytic lymphohistiocytosis
41. Interferon gamma is a marker for histiocytosis X cells in skin
42. Elevation of serum Fas ligand in patients with hemophagocytic syndrome and Diamond-Blackfan anemia
43. Prognosis of children with virus-associated hemophagocytic syndrome and malignant histiocytosis: Correlation with levels of serum interleukin-1 and tumor necrosis factor
44. Oversecretion of IL-18 in haemophagocytic lymphohistiocytosis: A novel marker of disease activity
45. Serum levels of interferon-gamma, cytotoxic factor and soluble IL-2 receptor in childhood hemophagocytic syndrome
46. Interferongamma (IFN-gamma) and interleukin 10 double-positive T-cells as potent activators of an uncontrolled hyperin-flammatory response in patients with familial and infection-associated histiocytosis
47. Neuron-specific enolase in hemophagocytic lymphohistiocytosis: A potential indicator for macrophage activation
48. Hemophagocytosis as a para-neoplastic syndrome in NK cell leukemia
49. The relationship of Langerhans cell histiocytosis to acute leukemia, lymphomas, and other solid tumors
50. CD40 expression by human monocytes: Regulation by cytokines and activation of monocytes by the ligand for CD40
51. Activation of human dendritic cells through CD40 cross-linking
52. CD40 and CD154 in cell-mediated immunity
53. Induction, regulation, and function of soluble TRAP (CD40-ligand) during interaction of primary CD4+ CD45RA+ T-cells with dendritic cells
54. Dendritic cells as a major source of macrophage-derived chemokin/CCL22 in vitro and in vivo
55. Viruses and Langerhans cell histiocytosis: Is there a link?